FDA D.I.S.C.O. Burst Edition: FDA approval of Bizengri (zenocutuzumab-zbco) for Treatment of adul...
Рет қаралды 340
Күн бұрынFDA D.I.S.C.O. Burst Edition: FDA approval of Bizengri (zenocutuzumab-zbco) for Treatment of adults with advanced unresectable or metastatic pancreatic adenocarcinoma harboring a neuregulin 1 (NRG1) gene fusion with disease progression on or after prior systemic therapy
FDA D.I.S.C.O. Burst Edition: FDA approval of Ryoncil (remestemcel-L-rknd) for steroid-refractory...
U.S. Food and Drug Administration
Рет қаралды 364
U.S. Food and Drug Administration
Рет қаралды 1,5 М.
Jason Derulo
Рет қаралды 14 МЛН
U.S. Food and Drug Administration
Рет қаралды 1,4 М.
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic aci...
U.S. Food and Drug Administration
Рет қаралды 285
U.S. Food and Drug Administration
Рет қаралды 1,2 М.
U.S. Food and Drug Administration
Рет қаралды 697
U.S. Food and Drug Administration
Рет қаралды 579
U.S. Food and Drug Administration
Рет қаралды 804
U.S. Food and Drug Administration
Рет қаралды 542
U.S. Food and Drug Administration
Рет қаралды 488
U.S. Food and Drug Administration
Рет қаралды 335
U.S. Food and Drug Administration
Рет қаралды 543
Jason Derulo
Рет қаралды 14 МЛН